Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
1400O Final overall survival for the phase III, KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+ advanced, unresectable or metastatic G/GEJ adenocarcinoma
Y. Y. Janjigian, Akihito Kawazoe, Y. Bai, Jiayue Xu, Sara Lonardi, J-P. Metges and 14 more
- Rank
- 58 of 3,853
- Percentile
- top 1.6%
- Where
- Annals of Oncology, 2024
- Citations
- 45
From the 2024 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.